CIK: 1431445 - Address: C/o Clarus Ventures, LLC, 101 Main Street, Suite 1210, Cambridge, MA 02142
12 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret3112-1-1-3-1-2-25-6
S%wins83678358678374

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/17/15 16:54
6/15/15
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticClarus Lifesciences I, L.P.MATS.m-59014.301-41-22,237D-2229-31770-100-61-16-34
6/12/15 16:58
6/11/15
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticClarus Lifesciences I, L.P.MATS.m-45114.271-32-12,279D-16210860001-61-10-37
6/10/15 19:02
6/8/15
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticClarus Lifesciences I, L.P.MATS.m-35214.281-25-12,310D-17203510320-1-12-2-8-38
6/3/15 17:21
6/1/15
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticClarus Lifesciences I, L.P.MATS.m-52114.291-36-22,335D-159051469-3-1-100-7-36
3/24/15 17:20
3/20/15
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticClarus Lifesciences I, L.P.MATS.m-77414.492-53-22,371D-31-11810-1-2-4-6-6-410-31
3/19/15 17:44
3/17/15
OXFDOxford Immunotec Global PlcX0HealthDiagnIn Vitro & In Vivo DiagnosticClarus Lifesciences I, L.P.MATS.m-2,26114.651-154-62,425D-3633717474-1-9-7-22-31
8/10/12 17:15
8/8/12
GMEDGlobus Medical IncDEHealthMdEqSurgical & Medical InstrumentClarus Lifesciences I, L.P.MATS.d-8,97511.1612-804-107,244I003190725
11/10/10 16:05
11/8/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsClarus Lifesciences I, L.P.MATS.m-6,0024.8233-1,245-166,669I984156735444599701-4-21-16-23-44
11/5/10 17:17
11/3/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsClarus Lifesciences I, L.P.MATS.m-7,9304.5831-1,733-187,914I9801648646484764-142-20-15-15-41
11/2/10 18:18
10/29/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsClarus Lifesciences I, L.P.MATS.m-26,2895.0625-5,194-359,647I999162554568416677010-6-8-7-31
10/12/10 19:17
10/8/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsClarus Lifesciences I, L.P.MATS.m-1,9303.508-552-414,840I5945111-2171978-6-5402616-6
7/15/10 18:51
7/13/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsClarus Lifesciences I, L.P.MATS-5833.536-165-115,392I27864727322460-5-5-73356

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact